EXAGEN INC. (XGN) › Capital ExpendituresEXAGEN INC. (XGN) — Capital ExpendituresAnnual figures by period end, from SEC filings.2018-12-31: $199.0K2019-12-31: $403.0K2020-12-31: $455.0K2021-12-31: $2.37M2022-12-31: $4.32M2023-12-31: $828.0K2024-12-31: $515.0K2025-12-31: $641.0K$641.0K2018-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$641.0K+24.5%2026-03-10From 2025-01-012024-12-31$515.0K-37.8%2026-03-10From 2024-01-012023-12-31$828.0K-80.8%2025-03-11From 2023-01-012022-12-31$4.32M+82.2%2024-03-18From 2022-01-012021-12-31$2.37M+420.9%2023-03-20From 2021-01-012020-12-31$455.0K+12.9%2022-03-22From 2020-01-012019-12-31$403.0K+102.5%2021-03-16From 2019-01-012018-12-31$199.0K—2020-03-25From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)